Trevena
IPOTrevena, Inc.
Public · King of Prussia, United States · Founded 2007 · $35.0M raised
- Headquarters
- King of Prussia, Pennsylvania
- Employees
- 51–200
- Founded
- 2007
- Business Model
- B2B
- Website
- trevena.com
- Total Funding
- $35.0M
- Last Round
- $35.0M Series BJul 2010
- Rounds
- 1
- Type
- Public
About
Discovering biased GPCR ligands that unlock new biology and avoid side effects as medicines for cardiovascular diseases, pain and inflammation
Summary
Trevena is a Biotech company based in King of Prussia, United States, founded in 2007. It has raised $35.0M in total across 1 round, most recently a $35.0M Series B round in Jul 2010. Investors include Polaris Partners.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2010
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...